Go Pro

William Blair Investment Management LLC Takes $1.21 Million Position in Corteva, Inc. $CTVA

Corteva logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • William Blair Investment Management acquired a new 14,319-share stake in Corteva worth approximately $1.21 million. Institutional investors collectively own 81.54% of the company.
  • Analyst sentiment remains favorable, with 14 Buy ratings and nine Holds producing a consensus “Moderate Buy” rating and an average price target of $91.50.
  • Corteva exceeded quarterly EPS expectations, reporting $2.30 versus the $2.24 estimate, though revenue fell 1.2% year over year to $6.38 billion. The company declared a quarterly dividend of $0.18 per share, equivalent to a 0.9% annual yield.
  • MarketBeat previews top five stocks to own in September.

William Blair Investment Management LLC acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,319 shares of the company's stock, valued at approximately $1,213,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in CTVA. Arbejdsmarkedets Tillaegspension purchased a new stake in Corteva in the fourth quarter worth $23,679,000. Bank of New York Mellon Corp bought a new position in Corteva in the 2nd quarter worth $392,447,000. Leonteq Securities AG purchased a new stake in shares of Corteva in the 4th quarter worth about $2,350,000. Brandes Investment Partners LP boosted its stake in shares of Corteva by 1.1% during the 4th quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company's stock valued at $155,009,000 after purchasing an additional 24,985 shares in the last quarter. Finally, Twin Capital Management Inc. increased its position in shares of Corteva by 178.9% during the fourth quarter. Twin Capital Management Inc. now owns 25,394 shares of the company's stock valued at $1,702,000 after buying an additional 16,288 shares during the period. Institutional investors own 81.54% of the company's stock.

Analyst Upgrades and Downgrades

CTVA has been the topic of several research reports. Royal Bank Of Canada lifted their price objective on Corteva from $97.00 to $103.00 and gave the company an "outperform" rating in a research report on Tuesday, July 21st. Bank of America lifted their price target on Corteva from $90.00 to $96.00 and gave the company a "buy" rating in a research report on Monday, July 20th. Mizuho increased their price objective on Corteva from $96.00 to $97.00 and gave the stock an "outperform" rating in a report on Tuesday, July 14th. Zacks Research cut shares of Corteva from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 11th. Finally, CICC Research increased their price target on shares of Corteva from $80.00 to $93.00 and gave the stock an "outperform" rating in a research note on Wednesday, May 13th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, Corteva currently has a consensus rating of "Moderate Buy" and a consensus price target of $91.50.

Get Our Latest Report on Corteva

Corteva Stock Up 0.1%

CTVA stock opened at $81.84 on Monday. The business has a 50 day moving average of $82.13 and a 200 day moving average of $80.26. The firm has a market cap of $54.60 billion, a PE ratio of 54.20, a price-to-earnings-growth ratio of 2.51 and a beta of 0.57. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $90.97. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA - Get Free Report) last released its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analysts' expectations of $6.60 billion. During the same period in the prior year, the firm posted $2.20 earnings per share. The company's quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, research analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's dividend payout ratio is presently 47.68%.

Corteva Profile

(Free Report)

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

See Also

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Corteva Right Now?

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines